Evidence map›Paper›PMID 41680383›Full record

ArticleMolecular imaging and biology2026

Exploration of the Feasibility of One-Day Dual-Low-Activity

Wenjin Zhao, Lifang Pang, Yunze Xie, Wenxin Tang, Hongcheng Shi

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular imaging and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wenjin Zhao *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Lifang Pang *Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Yunze XieDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Wenxin TangDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, 200032, China. shi.hongcheng@zs-hospital.sh.cn.

Funding

Chinese National Key Clinical Specialty Program YWP2022-007Innovative Medical Device Application Demonstration Program of Shanghai Municipal Commission of Economy and Informatization 23SHS01200Key Program of Ministry of Industry and Information Technology of China CEIEC-2022-ZM02-0219National High-End Medical Equipment Popularization and Application Program 2024TGYY06
6 · The paper itself

Abstract

purposeThe standard 2-day dual-tracer PET protocol provides more information but is time consuming. Thus, this study aimed to validate the feasibility of 1-day PROCEDURES: Fourteen NENs patients who underwent 1-day

resultsThe 1-day protocol detected 39 out of 40 lesions in 14 patients, while the 2-day protocol detected 65 out of 66 lesions in 14 patients. No significant differences were observed in lesion detection (all P > 0.05). There was no significant difference in diagnostic confidence between the 1-day protocol and the 2-day protocol for

conclusionThe 1-day

Indexed as

Fluorodeoxyglucose F18Magnetic Resonance ImagingMultimodal ImagingNeuroendocrine TumorsOrganometallic CompoundsPositron-Emission TomographyAdultAgedFeasibility StudiesFemaleHumansMaleMiddle AgedFluorodeoxyglucose F18gallium Ga 68 dotatateOrganometallic Compounds18F-FDG68Ga-DOTATATEDual tracerNENPET/MR

Identifiers

PMID41680383

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.